BIOMAT Database Logo BIOMAT Database Logo

Stimulation of collagen synthesis by the anabolic steroid stanozolol. 1998

V Falanga, and A S Greenberg, and L Zhou, and S M Ochoa, and A B Roberts, and A Falabella, and Y Yamaguchi
University of Miami School of Medicine, Department of Dermatology, Miami Veterans Affairs Medical Center, Florida, USA.

There is evidence that anabolic steroids, which are derived from testosterone and have markedly less androgenic activity, promote tissue growth and enhance tissue repair; however, the mechanisms involved in their anabolic activities remain unclear. In this report, we measured the effect of the anabolic steroid stanozolol on cell replication and collagen synthesis in cultures of adult human dermal fibroblasts. Stanozolol (0.625-5 microg per ml) had no effect on fibroblast replication and cell viability (p = 0.764) but enhanced collagen synthesis (p < 0.01) in a dose-dependent manner (r = 0.907). Stanozolol also increased (by 2-fold) the mRNA levels of alpha1 (I) and alpha1 (III) procollagen and, to a similar extent, upregulated transforming growth factor-beta1 (TGF-beta1) mRNA and peptide levels (p < 0.001). There was no stimulation of collagen synthesis by testosterone. The stimulatory effects of stanozolol on collagen synthesis were blocked by a TGF-beta1 anti-sense oligonucleotide, by antibodies to TGF-beta, and in dermal fibroblast cultures derived from TGF-beta1 knockout mice. We conclude that collagen synthesis is increased by the anabolic steroid stanozolol and that, for the most part, this effect is due to TGF-beta1. These findings point to a novel mechanism of action of anabolic steroids.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D011347 Procollagen A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains. Protocollagen,Procollagen Type M
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

V Falanga, and A S Greenberg, and L Zhou, and S M Ochoa, and A B Roberts, and A Falabella, and Y Yamaguchi
Stanozolol, a new anabolic steroid.
January 1962, The Journal of new drugs,
V Falanga, and A S Greenberg, and L Zhou, and S M Ochoa, and A B Roberts, and A Falabella, and Y Yamaguchi
The anabolic steroid, Stanozolol--its evaluation in debilitated children.
November 1965, Clinical pediatrics,
V Falanga, and A S Greenberg, and L Zhou, and S M Ochoa, and A B Roberts, and A Falabella, and Y Yamaguchi
Response of human skeletal muscle to the anabolic steroid stanozolol.
October 1988, BMJ (Clinical research ed.),
V Falanga, and A S Greenberg, and L Zhou, and S M Ochoa, and A B Roberts, and A Falabella, and Y Yamaguchi
Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis.
November 1982, Metabolism: clinical and experimental,
V Falanga, and A S Greenberg, and L Zhou, and S M Ochoa, and A B Roberts, and A Falabella, and Y Yamaguchi
Alteration of hormone levels in normal males given the anabolic steroid stanozolol.
July 1984, Clinical endocrinology,
V Falanga, and A S Greenberg, and L Zhou, and S M Ochoa, and A B Roberts, and A Falabella, and Y Yamaguchi
Effects of the anabolic steroid stanozolol on cells derived from human bone.
May 1988, Clinical science (London, England : 1979),
V Falanga, and A S Greenberg, and L Zhou, and S M Ochoa, and A B Roberts, and A Falabella, and Y Yamaguchi
American Academy of Dermatology 1998 Awards for Young Investigators in Dermatology. The anabolic steroid stanozolol upregulates collagen synthesis through the action of transforming growth factor-beta1.
August 1998, Journal of the American Academy of Dermatology,
V Falanga, and A S Greenberg, and L Zhou, and S M Ochoa, and A B Roberts, and A Falabella, and Y Yamaguchi
A double-blind trial of an anabolic steroid (stanozolol) in the disabled elderly.
February 1977, Rheumatology and rehabilitation,
V Falanga, and A S Greenberg, and L Zhou, and S M Ochoa, and A B Roberts, and A Falabella, and Y Yamaguchi
USE OF ANABOLIC STEROID, STANOZOLOL, TO PROMOTE WEIGHT GAIN IN UNDERWEIGHT PATIENTS.
June 1964, Clinical medicine (Northfield, Ill.),
V Falanga, and A S Greenberg, and L Zhou, and S M Ochoa, and A B Roberts, and A Falabella, and Y Yamaguchi
Effects of the anabolic steroid stanozolol on growth and protein metabolism in the rat.
September 1987, The Journal of endocrinology,
Copied contents to your clipboard!